Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2022-02-01

FDA Approved: ISOSORBIDE MONONITRATE — Supplemental Application (Lannett Company, Inc.)

View source ↗

Summary

FDA approved a supplemental application for Isosorbide Mononitrate from Lannett Company, Inc., indicating an additional labeling action for the product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Isosorbide Mononitrate (isosorbide mononitrate)

Snippet

SUPPL AP for ISOSORBIDE MONONITRATE (ISOSORBIDE MONONITRATE)